Clinical Trials

Updated 11/9/10

General Sarcoma

2007-0395: (SARC 009): A Phase II Trial of Dasatinib in Advanced Sarcoma
2008-0547: Ph III Trabectedin vs Dox (Doxorubicin) First Line in pts with TRS (Translocation-Related Sarcomas)
2005-0524: Trabectedin for patients with Sarcoma chemo resistance. ET743-SAR-3002
2010-0191: Temsirolimus and IGF-1R Inhibitor for Sarcoma

2009-0296: Ph. II ,non-randomized multicenter study of 5 year adjuvant Gleevec in patients at significant risk for recurrence following complete resection of primary GIST
2008-0693: Ph III Nilotinib vs Imatinib unresectable/met GIST

LAB08-0151: Tissue banking protocol- biomarkers predictive of response to targeted therapy

2008-0276: Mucositis: A Phase II study to evaluate the preliminary efficacy assessment of Caphosol in patients with sarcoma receiving multicycle chemotherapy with doxorubicin and ifosfamide or cisplatin
2005-0099: Thrombocytopenia: Phase I/II Study of AMG 531 in Patients with Advanced Malignancy Receiving Treatment with Chemotherapy
2009-0775: Nausea/Vomiting: -Dose/Schedule finding study of Palonosetron in Sarcoma patients receiving multi-day chemotherapy with adriamycin and ifosfamide (AI)
2008-0664: A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV during the Previous Cycle of Low Emetogenic chemotherapy (LEC)
2010-0438: Anemia: A Phase 1 Safety Study of LY2787106 in Patients with Cancer and Anemia

Clinical trials are research studies that test new cancer drugs, diagnostic procedures and therapies on humans.